The human body’s ability to heal is amazing. Collaborating with some of the country’s leading medical schools and Department of Defense consultants, HS Pharmaceuticals has found promising results for topical applications of the HSX silicate-based nanoparticle technology for complex wound care.
Our innovative topically-administered new drug candidate has the unique ability to promote the rapid healing of complex/infected wounds and burns while also dramatically minimizing scar formation. The ointment activates a localized immune response to the wounds site, clears foreign pathogens and rapidly accelerates healing.
Topical administration of various formulations have shown antibacterial properties in the technology’s applications, offering great grant funding potential for further research and development testing for licensees.